72 related articles for article (PubMed ID: 3708618)
1. Phase II trial of chemotherapy with cisplatin and etoposide in non-small cell lung cancer.
Pallares C; Piera JM; Barnadas A; Izquierdo A; Lopez Lopez JJ
Cancer Treat Rep; 1986 May; 70(5):677. PubMed ID: 3708618
[No Abstract] [Full Text] [Related]
2. Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatin.
Dhingra HM; Valdivieso M; Booser DJ; Umsawasdi T; Carr DT; Chiuten DF; Murphy WK; Issell BF; Spitzer G; Farha P
Cancer Treat Rep; 1984 Apr; 68(4):671-3. PubMed ID: 6538811
[TBL] [Abstract][Full Text] [Related]
3. Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.
Ardizzoni A; Fusco V; Gulisano M; Pronzato P; Baracco F; Capaccio A; Pastorino G; Nosenzo M; Felletti R; Fabiano F
Cancer Treat Rep; 1987 Dec; 71(12):1311-2. PubMed ID: 2825994
[No Abstract] [Full Text] [Related]
4. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
Joss RA; Alberto P; Obrecht JP; Barrelet L; Holdener EE; Siegenthaler P; Goldhirsch A; Mermillod B; Cavalli F
Cancer Treat Rep; 1984 Sep; 68(9):1079-84. PubMed ID: 6090014
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
Figlin RA; Crowley JJ; Jacobs EL; Muirhead M; Goodwin JW; Rinehart JJ; Livingston RB
Cancer; 1996 Sep; 78(5):998-1003. PubMed ID: 8780537
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy and side effects of chemotherapy for primary lung cancer with cisplatin and etoposide].
Tsutsumi T; Kawakami A; Ozawa Y; Kawaguchi H; Fujii H; Sawano T; Asamoto H
Gan To Kagaku Ryoho; 1991 May; 18(6):1003-6. PubMed ID: 1851407
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of etoposide, vincristine, and high-dose cisplatin in advanced non-small cell lung cancer.
Bertrand M; Multhauf P; Presant C; Rappaport D; Blayney DW; Carr BI; Cecchi G; Doroshow JH; Emont E; Goldberg D
Cancer Treat Rep; 1985 Nov; 69(11):1335-6. PubMed ID: 4092199
[No Abstract] [Full Text] [Related]
9. Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lung.
Ardizzoni A; Canobbio L; Pronzato P; Rubagotti A; De Palma M; Baracco F; Serrano J; Serrano S; Faravelli B; Nosenzo M
Cancer Treat Rep; 1986 Jul; 70(7):891-2. PubMed ID: 3719580
[TBL] [Abstract][Full Text] [Related]
10. Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188.
Lokich J; Auerbach M; Essig L; Fryer J; Fryer D
J Infus Chemother; 1995; 5(2):70-2. PubMed ID: 8521238
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with vindesine, etoposide, and cisplatin in non-small cell lung cancer: a pilot study of the Southeastern Cancer Study Group.
Hainsworth JD; Porter LL; Johnson DH; Hande KR; Wolff SN; Birch R; Enas G; Greco FA
Cancer Treat Rep; 1986 Mar; 70(3):339-41. PubMed ID: 3955545
[TBL] [Abstract][Full Text] [Related]
12. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
Saito R; Tsuchiya S; Minato K; Ishizuka T
Nihon Gan Chiryo Gakkai Shi; 1988 Mar; 23(3):744-51. PubMed ID: 2841389
[No Abstract] [Full Text] [Related]
13. A phase II study of neoadjuvant chemotherapy with cisplatin epirubicin and VP-16 for stage III unresectable non-small cell lung cancer.
Iacobelli S; Irtelli L; Sacco R; Martino M; Mascitelli E; Basilico L; Scognamiglio M; Natoli C; Fusco O; Tinari N; Beltrami V
Anticancer Res; 1998; 18(3B):2081-4. PubMed ID: 9677471
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin, etoposide, and vincristine combination chemotherapy in the treatment of non-small cell lung cancer.
Watanabe A; Ichiyama S; Shimokata K; Nagura E; Saito H; Saka H; Nomura F; Sakai S; Saito H
Nagoya J Med Sci; 1993 Mar; 55(1-4):41-6. PubMed ID: 8247105
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
16. Different fraction schedules and combinations with chemotherapy in radiation treatment of non-small cell lung cancer.
Brattström D; Bergqvist M; Hesselius P; Wagenius G; Brodin O
Anticancer Res; 2000; 20(3B):2087-90. PubMed ID: 10928157
[TBL] [Abstract][Full Text] [Related]
17. Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
Jett JR; Hatfield AK; Hillman S; Bauman MD; Mailliard JA; Kugler JW; Morton RF; Marks RS; Levitt R
Cancer; 2003 May; 97(10):2498-503. PubMed ID: 12733149
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
Mazzei T; Marino C; Nozzoli F; Lopes-Pegna A; Righi R; Santomaggio C; Lamanna S; Periti P
Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172
[TBL] [Abstract][Full Text] [Related]
19. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
20. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
